These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35198288)

  • 1. Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines.
    Dutta S; Kaur R; Charan J; Bhardwaj P; Ambwani SR; Babu S; Goyal JP; Haque M
    Cureus; 2022 Jan; 14(1):e21376. PubMed ID: 35198288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database.
    Jeet Kaur R; Dutta S; Charan J; Bhardwaj P; Tandon A; Yadav D; Islam S; Haque M
    Int J Gen Med; 2021; 14():3909-3927. PubMed ID: 34349544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare Workers.
    Wi YM; Kim SH; Peck KR
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Events Following COVID-19 Vaccination in Adolescents: Insights From Pharmacovigilance Study of VigiBase.
    Kim DH; Kim JH; Oh IS; Choe YJ; Choe SA; Shin JY
    J Korean Med Sci; 2024 Mar; 39(8):e76. PubMed ID: 38442719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Events Following BNT162b2 mRNA COVID-19 Vaccine Immunization among Healthcare Workers in a Tertiary Hospital in Johor, Malaysia.
    Tan AY; Chang CT; Yu YK; Low YX; Razali NFM; Tey SY; Lee SWH
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of COVID-19 and Vaccine on the Human Nervous System.
    Chen F; Cao P; Liu H; Cai D
    Neuroendocrinology; 2022; 112(11):1046-1057. PubMed ID: 35316815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Adverse Events Following COVID-19 Vaccination: Analysis of VAERS Reports.
    Riad A; Põld A; Kateeb E; Attia S
    Front Public Health; 2022; 10():952781. PubMed ID: 35899169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral adverse events following COVID-19 and influenza vaccination in Australia.
    Riad A; Issa J; Attia S; Dušek L; Klugar M
    Hum Vaccin Immunother; 2023 Aug; 19(2):2253589. PubMed ID: 37734344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Antibody Response Comparison and Adverse Reaction Analysis in Healthcare Workers Vaccinated with the BNT162b2 or ChAdOx1 COVID-19 Vaccine.
    Lim SH; Choi SH; Kim B; Kim JY; Ji YS; Kim SH; Kim CK; Kim T; Choo EJ; Moon JE; Yun J; Park SK
    Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety Profiles of mRNA COVID-19 Vaccines Using World Health Organization Global Scale Database (VigiBase): A Latent Class Analysis.
    Lee MT; Choi W; You SH; Park S; Kim JY; Nam DR; Lee JW; Jung SY
    Infect Dis Ther; 2023 Feb; 12(2):443-458. PubMed ID: 36520333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
    Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
    Front Immunol; 2021; 12():669010. PubMed ID: 34093567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.
    Jarynowski A; Semenov A; Kamiński M; Belik V
    J Med Internet Res; 2021 Nov; 23(11):e30529. PubMed ID: 34662291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can reactogenicity predict immunogenicity after COVID-19 vaccination?
    Hwang YH; Song KH; Choi Y; Go S; Choi SJ; Jung J; Kang CK; Choe PG; Kim NJ; Park WB; Oh MD
    Korean J Intern Med; 2021 Nov; 36(6):1486-1491. PubMed ID: 34038996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Safety of mRNA-1273, BNT162b2 and JNJ-78436735 COVID-19 Vaccines: Safety Monitoring for Adverse Events Using Real-World Data.
    Sa S; Lee CW; Shim SR; Yoo H; Choi J; Kim JH; Lee K; Hong M; Han HW
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty
    Held J; Esse J; Tascilar K; Steininger P; Schober K; Irrgang P; Alsalameh R; Tenbusch M; Seggewies C; Bogdan C
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database.
    Merino D; Gérard AO; Van Obberghen EK; Ben Othman N; Ettore E; Giordana B; Viard D; Rocher F; Destere A; Benoit M; Drici MD
    Front Pharmacol; 2022; 13():909412. PubMed ID: 35668936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review.
    Amanzio M; Mitsikostas DD; Giovannelli F; Bartoli M; Cipriani GE; Brown WA
    Lancet Reg Health Eur; 2022 Jan; 12():100253. PubMed ID: 34729549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Disproportionality Analysis for Association of Systemic Capillary Leak Syndrome with COVID-19 Vaccination Using the World Health Organization Pharmacovigilance Database.
    Park J; Kim D; Song TJ
    Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.